Unveiling solitonic collisions in mechanical metamaterials. [PDF]
Miyazawa Y +3 more
europepmc +1 more source
Developmental and Epileptic Encephalopathy due to Biallelic Pathogenic Variants in PIGM
ABSTRACT Objective PIGM encodes a critical enzyme in the glycosylphosphatidylinositol (GPI)‐anchor biosynthesis pathway. While promoter‐region mutations in PIGM have been associated with a relatively mild phenotype characterized by portal vein thrombosis and absence seizures, recent evidence suggests that coding‐region mutations result in a more severe
Júlia Sala‐Coromina +11 more
wiley +1 more source
Occupational Exposure to Blue Light Emitted from Neonatal Phototherapy Devices Alters the Sleep Quality of NICU Nurses. [PDF]
Zahadatpour Z +5 more
europepmc +1 more source
Epigenetic reprogramming in hematopoietic stem and progenitor cells (HSPCs) and downstream myeloid cells, mediated by H3.3 downregulation and endogenous retroelement (ERE) overexpression, contributes to the progression of multiple sclerosis (MS). ABSTRACT Background Skewed myelopoiesis in the bone marrow has been identified as a key driver of multiple ...
Li‐Mei Xiao +6 more
wiley +1 more source
Inflammation-associated brain functional network topological disruption in female nurses with SWSD: associations with symptoms and transcriptomics. [PDF]
Gu SY +12 more
europepmc +1 more source
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane +43 more
wiley +1 more source
Wafer-Level Transfer of GaN-on-Si Light-Emitting Devices via SiO<sub>2</sub>-SiO<sub>2</sub> Direct Bonding: Strain Evolution and Optoelectronic Performance. [PDF]
Zhang S, Zhang S, Fan Q, Ni X, Gu X.
europepmc +1 more source
Quantifying the Impact of Ocrelizumab on Paramagnetic Rim Lesions in Multiple Sclerosis
ABSTRACT Paramagnetic rim lesions (PRLs) are a subset of chronic active multiple sclerosis (MS) lesions marked by iron‐laden microglia and macrophages. Ocrelizumab, a monoclonal antibody targeting CD20+ B cells, suppresses acute MS activity, but its effect on PRLs remains unclear. In a longitudinal study of 29 ocrelizumab‐treated patients with at least
Kimberly H. Markowitz +9 more
wiley +1 more source
Multifunctional ligand engineering for pure-blue halide perovskite nanocrystal LEDs. [PDF]
Swihart MT.
europepmc +1 more source

